Literature DB >> 3079699

Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states.

D Collen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079699     DOI: 10.2165/00003495-198631010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  24 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Authors:  W Weimar; J Stibbe; A J van Seyen; A Billiau; P De Somer; D Collen
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

3.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

4.  Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus.

Authors:  O Matsuo; D C Rijken; D Collen
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

5.  Clot-selective coronary thrombolysis with tissue-type plasminogen activator.

Authors:  S R Bergmann; K A Fox; M M Ter-Pogossian; B E Sobel; D Collen
Journal:  Science       Date:  1983-06-10       Impact factor: 47.728

6.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

7.  Purification and partial characterization of plasminogen activator from human uterine tissue.

Authors:  D C Rijken; G Wijngaards; M Zaal-de Jong; J Welbergen
Journal:  Biochim Biophys Acta       Date:  1979-09-29

8.  Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.

Authors:  F Van de Werf; S R Bergmann; K A Fox; H de Geest; C F Hoyng; B E Sobel; D Collen
Journal:  Circulation       Date:  1984-03       Impact factor: 29.690

9.  Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.

Authors:  D Collen; J M Stassen; M Verstraete
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

10.  Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.

Authors:  W Flameng; F Van de Werf; J Vanhaecke; M Verstraete; D Collen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  2 in total

Review 1.  Cardiovascular drugs.

Authors:  P Vermeij
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

2.  Prediction of the three-dimensional structure of the enzymatic domain of t-PA.

Authors:  A Heckel; K M Hasselbach
Journal:  J Comput Aided Mol Des       Date:  1988-04       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.